Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Meningococcal disease
SAGE documentation
GRADE table
Clear all
Type of publications
SAGE documentation
(6)
Topics
GRADE table
(6)
Available to download in languages
English (EN)
(6)
Regions
Countries
Diseases
COVID-19
(2)
Meningococcal disease
(4)
Cholera
(1)
Diphtheria
(1)
Haemophilus influenzae type B
(3)
Human papillomavirus (HPV)
(9)
Influenza
(11)
Japanese encephalitis
(9)
Pertussis
(2)
Rubella
(1)
Typhoid
(2)
Vaccine topics
Target population
Newborn
(3)
Publication date
2022
(2)
2015
(4)
6 results found
2022
∙
SAGE
Annexes to the interim recommendations for use of the Bharat Biotech BBV152 COVAXIN® vaccine against COVID-19
2022
∙
SAGE
Annexes to the interim recommendations for use of the Cansino Ad5-nCoV-S vaccine (Convidecia ®) against COVID-19
2015
∙
SAGE
Duration of protection conferred by MenA conjugate vaccination in immunocompetent children (3 to 24 months of age) against serogroup A meningococcal disease
2015
∙
SAGE
Efficacy of a single-dose MenA conjugate vaccination in immunocompetent children (9 to 24 months of age) against serogroup A meningococcal disease
2015
∙
SAGE
Efficacy of a two dose schedule of MenA conjugate vaccination in immunocompetent children (3 to 9 months of age) against serogroup A meningococcal disease
2015
∙
SAGE
Safety of MenA conjugate vaccination in immunocompetent children (3 to 24 months of age)
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register